Hepion Pharmaceuticals, Inc. (CTRVP) Operating cash flow 2016–2025
Hepion Pharmaceuticals, Inc. (CTRVP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.3MFY2025 · since FY2016: -$19.2M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +82.0% |
| FY2024 | -$18.2M | +55.4% |
| FY2023 | -$40.9M | -17.0% |
| FY2022 | -$35.0M | -12.0% |
| FY2021 | -$31.2M | -93.2% |
| FY2020 | -$16.2M | -113.7% |
| FY2019 | -$7.6M | +51.6% |
| FY2018 | -$15.6M | — |
| FY2016 | -$19.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice